INCORPORATION

1998

1999

Acquisitions of manufacturing plants in Jiangsu Prov. and Shandong Prov, China

2000

Patent approval for AGC drug processing

2001

Vanworld opens its new headquarters in Hong Kong

2001

Acquisition of patented drug: RNA+Heparin compound formulation

2002

GMP accreddited clinical trials of AGC in 3 Grade A hospitals in Beijing

2003

SFDA approval of new AGC drug license

2004

Awarded production license and launch of AGC ampoule

2005

Granted patent for intermediate material 'inflamed rabbit skin'
Awarded as a "New Advanced Technology Product"

2006

SFDA approval of symptomatic neuralgia indication

2012

Filing of optimized AGC dosage based on new research insights